Chang-qing Du
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Farnesyl Pyrophosphate Synthase Blocker Ibandronate Reduces Thoracic Aortic Fibrosis in Diabetic Rats.
Journal: The American journal of the medical sciences
Published: June 11, 2018
Congenital Absence of Left Coronary Artery Accompanied by Premature Ventricular Complexes.
Journal: The American journal of the medical sciences
Published: December 13, 2017
Farnesyl pyrophosphate synthase inhibitor, ibandronate, improves endothelial function in spontaneously hypertensive rats.
Journal: Molecular medicine reports
Published: April 09, 2015
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
Journal: International journal of molecular medicine
Published: January 28, 2015
Alteration of mevalonate pathway in proliferated vascular smooth muscle from diabetic mice: possible role in high-glucose-induced atherogenic process.
Journal: Journal of diabetes research
Published: January 25, 2015
Effects of total flavones from Dendranthema morifolium on vasocontraction and proliferation of vascular smooth muscle cells.
Journal: Molecular medicine reports
Published: November 16, 2014
Inhibition of farnesyl pyrophosphate synthase prevents norepinephrine-induced fibrotic responses in vascular smooth muscle cells from spontaneously hypertensive rats.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: March 27, 2013
Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Journal: Cardiovascular research
Published: November 28, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026